Surgery of metastatic melanoma after systemic therapy - the SUMMIST trial: study protocol for a randomized controlled trial
Acta Oncol
.
2021 Jan;60(1):52-55.
doi: 10.1080/0284186X.2020.1846213.
Epub 2020 Nov 30.
Authors
Carl Jacob Holmberg
1
2
3
,
Dimitrios Katsarelias
1
2
3
,
Henrik Jespersen
4
5
,
Ana Carneiro
6
,
Nils O Elander
7
,
Hildur Helgadottir
8
,
Karolin Isaksson
9
10
,
Malin Jansson
11
,
Sara Wirén
12
,
Gustav J Ullenhag
13
14
,
Lars Ny
4
15
,
Roger Olofsson Bagge
1
2
3
Affiliations
1
Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
2
Department of Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
3
Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
4
Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
5
Akershus University Hospital, Nordbyhagen, Norway.
6
Department of Oncology, Lund University Hospital, Lund, Sweden.
7
Department of Oncology and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
8
Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
9
Department of Clinical Sciences, Surgery, Lund University, Lund, Sweden.
10
Department of Surgery, Central Hospital Kristianstad, Kristianstad, Sweden.
11
Department of Surgical and Perioperative Sciences, Umeå University and Umeå University Hospital, Umeå, Sweden.
12
Department of Radiation Sciences, Oncology, Umeå University Hospital, Umeå, Sweden.
13
Department of Immunology, Genetics and Pathology, Science of Life Laboratory, Uppsala University, Uppsala, Sweden.
14
Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.
15
Department of Oncology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
PMID:
33252282
DOI:
10.1080/0284186X.2020.1846213
No abstract available
Publication types
Clinical Trial Protocol
Letter
MeSH terms
Humans
Melanoma* / drug therapy
Neoplasms, Second Primary*
Randomized Controlled Trials as Topic
Skin Neoplasms* / drug therapy